Table 2.
The prevalence of anti‐SARS‐CoV‐2 IgG antibodies in patients with IgG autoantibodies against ACE2 (n = 17) and without them (n = 1122)
Anti‐SARS‐CoV‐2 | Group | p Value (Pearson's χ2 test) | |
---|---|---|---|
IgG antibody | ACE2 IgG antibodies | No ACE2 IgG antibodies | |
Anti‐RBD (% of patients) | 88.2 | 76.3 | >0.05 (χ2 = 1.3) |
Anti‐S2 (% of patients) | 82.4 | 38.7 | 0.0003 (χ2 = 13.4) |
Anti‐N (% of patients) | 88.2 | 65.2 | 0.04 (χ2 = 3.9) |